Print PDF

Morris James Team is Editor-In-Chief and a Co-Authors of a New ANDA Litigation Book Published by the American Bar Association

May 21, 2012
Kenneth L. Dorsney, Mary Matterer, Richard Herrmann

Examining the intersection between the statutory and regulatory scheme governing approval of generic pharmaceuticals and U.S. patent law, this single-source guide balances perspectives from name-brand drug patentees and generic drug manufacturers. With a focus on current and developing law as well as practical strategies and tactics for litigation, it covers all steps in the litigation process. For more information, click here.

ANDA Litigation